Advocacy Drug Shortages

ASHP Expert Testifies Before House Committee on Drug Shortages

Published: September 14, 2023
Michael Ganio testifies before House committee
ASHP's Michael Ganio testifies before House committee (photo by Daniel Rosenbaum)

Today, Michael Ganio, ASHP’s senior director of pharmacy practice and quality, appeared before the House Energy and Commerce Committee’s Subcommittee on Health as it met to discuss legislative proposals to address generic drug shortages.

ASHP’s Drug Shortages List included 309 active, ongoing shortages as of July — the highest number in nearly a decade and close to the all-time high of 320 shortages.

“Without a way for purchasers to identify manufacturers with strong quality systems, there is no financial incentive for manufacturers to invest in quality management,” Ganio told the committee. “A diverse base of high-quality manufacturers and suppliers is critical to solving the drug shortage crisis and ensuring our nation’s healthcare security. This requires solutions in two areas: transparency of quality information and resiliency of production.”

Ganio outlined proposals that ASHP included in its Policy Solutions to Address the Drug Shortage Crisis released this summer. ASHP conducted a survey of its members that showed the severity of the problem, with nearly 60% of respondents reporting critical shortages of chemotherapy drugs.

Read Ganio’s entire testimony and watch the livestreamed hearing.

Posted September 14, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information